文献速递慢性肾脏病

慢性肾脏病全球健康不平等的荟萃分析

Global health inequalities of chronic kidney disease: a meta-analysis.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

该研究通过系统综述和荟萃分析发现,慢性肾脏病(CKD)总体患病率为13.0%,3-5期患病率为6.6%。患病率随年龄增长而升高,3-5期在女性中更高,且不同收入国家间存在差异,中低收入国家患病率较高。

要点

  • CKD总体患病率为13.0%,3-5期为6.6%。
  • 老年人群患病率更高,年龄、BMI、糖尿病和高血压与3-5期患病相关。
  • 3-5期患病率女性高于男性,中低收入国家患病率较高。

核心结论

  • CKD患病率存在年龄、性别和社会经济地位相关差异,需针对中低收入国家加强筛查和治疗。

研究设计与样本

  • 系统综述和荟萃分析,检索2014至2022年五个数据库,纳入119篇论文,分析29 159 948名参与者。

主要发现

  • CKD总体患病率为13.0%(95%CI 11.3-14.8),3-5期患病率为6.6%(95%CI 5.6-7.8)。
  • 老年人群患病率更高:1-5期为19.3%,3-5期为15.0%。
  • 3-5期患病率女性为7.5%,男性为6.4%;1-5期男性13.1%,女性13.2%。
  • 低、中、高收入国家总体患病率分别为11.4%、15.0%、10.8%;3-5期分别为4.0%、6.7%、6.8%。

临床怎么用

  • 应关注老年、女性及中低收入国家人群的CKD筛查与治疗。

局限性

  • 纳入研究中92%存在中高偏倚风险,异质性高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) is a significant contributor to global morbidity and mortality. This study investigated disparities in age, sex and socio-economic status in CKD and updated global prevalence estimates through systematic review and meta-analysis. METHODS: Five databases were searched from 2014 to 2022, with 14 871 articles screened, 119 papers included and data analysed on 29 159 948 participants. Random effects meta-analyses were conducted to determine overall prevalence, prevalence of stages 3-5 and prevalence in males and females. Influences of age, sex and socio-economic status were assessed in subgroup analyses and risk of bias assessment and meta-regressions were conducted to explore heterogeneity. RESULTS: The overall prevalence of CKD was 13.0% [95% confidence interval (CI) 11.3-14.8] and 6.6% (95% CI 5.6-7.8) for stages 3-5. The prevalence was higher in studies of older populations (19.3% for stages 1-5, 15.0% for stages 3-5) and meta-regression demonstrated an association of age, body mass index, diabetes and hypertension with prevalence of stages 3-5. The prevalence of CKD stages 1-5 was similar in males and females (13.1% versus 13.2%), but the prevalence of stages 3-5 was higher in females (6.4% versus 7.5%). Overall prevalence was 11.4%, 15.0% and 10.8% in low-, middle- and high-income countries, respectively; for stages 3-5, prevalence was 4.0%, 6.7% and 6.8%, respectively. Included studies were at moderate-high risk of bias in the majority of cases (92%) and heterogeneity was high. CONCLUSION: This study provides a comprehensive assessment of CKD prevalence, highlighting important disparities related to age, sex and socio-economic status. Future research should focus on targeted screening and treatment approaches, improving access to care and more effective data monitoring, particularly in low- and middle-income countries.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Duff R, Awofala O, Arshad MT, et al. Global health inequalities of chronic kidney disease: a meta-analysis. Nephrol Dial Transplant. 2024. PMID: 38389223. doi:10.1093/ndt/gfae048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。